Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:International clinical evidence-based guideline for Kleefstra Syndrome
Authors:ID Bouman, Arianne (Author)
ID Gaasterland, Charlotte M. W. (Author)
ID Sloof-Enthoven, Carla (Author)
ID Zdolšek Draksler, Tanja, Institut "Jožef Stefan" (Author)
ID Kleefstra, Tjitske (Author), et al.
Files:URL URL - Source URL, visit https://www.sciencedirect.com/science/article/pii/S1098360026003886?via%3Dihub
 
.pdf PDF - Presentation file, download (1,59 MB)
MD5: 09266C72456908AF7F48C3D1BD3AEF94
 
Language:English
Typology:1.02 - Review Article
Organization:Logo IJS - Jožef Stefan Institute
Abstract:Kleefstra syndrome (KLEFS1) is a rare monogenic neurodevelopmental disorder (mNDD) with multisystem involvement, caused by disruption of EHMT1 function, resulting in significant burden on affected individuals and their families. The current shortage of and globally scattered syndrome-specific knowledge has led to significant disparities in the access to and provision of evidence-based and individual-centered expert care. To address the challenges and improve outcomes for individuals with KLEFS1, an international KLEFS1 guideline consortium was formed consisting of 43 participants, both clinical experts and patient-representatives, from 15 different countries. The primary goal of the consortium was to develop a comprehensive and high-quality guideline for KLEFS1, aiming to enhance patient care, establish a uniform minimum international standard of care, and support decision-making. The current clinical guideline is evidence-based and includes 66 tailored recommendations to improve KLEFS1 care. The comprehensive methodological approach ensures broad consensus and supports effective implementation. Furthermore, this guideline serves as a valuable methodological model for guideline development in the context of rare disorders.
Keywords:Kleefstra syndrome, clinical guideline, treatment
Publication status:Published
Publication version:Submitted Version
Submitted for review:14.02.2025
Article acceptance date:14.01.2026
Publication date:20.01.2026
Publisher:Elsevier
Year of publishing:2026
Number of pages:str. 1-28, [1-9]
Numbering:Vol. 28, iss. , [article no.] 102070
Source:Nizozemska
PID:20.500.12556/DiRROS-25629 New window
UDC:616.899
ISSN on article:1530-0366
DOI:10.1016/j.gim.2026.102070 New window
COBISS.SI-ID:265560579 New window
Copyright:© 2026 Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics
Note:Nasl. z nasl. zaslona; Soavtorica iz Slovenije: Tanja Zdolšek Draksler; Opis vira z dne 21. 1. 2026;
Publication date in DiRROS:26.01.2026
Views:48
Downloads:23
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Genetics in medicine
Shortened title:Genet. med.
Publisher:Lippincott Williams & Wilkins, Nature Publishing Group
ISSN:1530-0366
COBISS.SI-ID:521566489 New window

Document is financed by a project

Funder:NWO - Netherlands Organisation for Scientific Research
Funding programme:Netherlands Organisation for Scientific Research (NWO)
Project number:015.014.036
Name:Aspasia

Funder:Netherlands Organization for Health Research and Development
Project number:91718310

Funder:ZonMW
Project number:10250022110003

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:20.01.2026
Applies to:Nerecenzirano različico (pre-proof)

Secondary language

Language:Slovenian
Keywords:sindrom Kleefstra, klinične smernice, obravnava bolnikov


Back